drugset / Trial / NCT00414726

Normobaric Oxygen Therapy in Acute Ischemic Stroke Trial

NCT00414726 ↗

RandomizedParallel-groupTriple-blindTreatment

Summary

The purpose of this study is to compare the safety and efficacy of treating individuals with acute ischemic stroke with normobaric oxygen therapy (NBO, given within 9 hours of symptom onset), to standard medical treatment.

Timeline

Start
2007-01
Primary completion
2009-06
Completion
2009-06

Outcome

Outcome not reported

Stopped: “Imbalance in deaths favoring control arm; deaths not attributed to treatment by the blinded external medical monitor.”

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Normobaric Oxygen Unknown — Inhaled

Indications